Nov, 10 2022

FDA Approves Tremelimumab in Combination with Durvalumab for Unresectable Hepatocellular Carcinoma

Learn about the latest treatments for Hepatocellular Carcinoma (HCC), including surgical options, targeted therapies like sorafenib, and promising combination treatments.



(PAGE 8 OF 1)

Client Testimonials